Area of research
Neurology · Cellular and Molecular Neuroscience
Research interest
Research interests include Parkinson's Disease Mechanisms and Treatments, Neurological disorders and treatments, Nuclear Receptors and Signaling, and Parkinson's Disease and Spinal Disorders.
Environmental toxicants and Parkinson's disease: recent evidence, risks, and prevention opportunities
<i>LRRK2</i> -associated parkinsonism with and without <i>in vivo</i> evidence of alpha-synuclein aggregates: longitudinal clinical and biomarker characterization
Neuronal α‐Synuclein Disease Stage Progression over 5 Years
The epidemiology of Parkinson's disease
A biological definition of neuronal α-synuclein disease: towards an integrated staging system for research
Epidemiology of Parkinson’s Disease: An Update
Occupational Pesticide Exposure in Parkinson’s Disease Related to <i>GBA</i> and <i>LRRK2</i> Variants
Staged Screening Identifies People with Biomarkers Related to Neuronal Alpha‐Synuclein Disease
Twelve Years of Drug Prioritization to Help Accelerate Disease Modification Trials in Parkinson’s Disease: The International Linked Clinical Trials Initiative
Eleven Years of Change: Disease Progression in Biomarker-Defined Sporadic Parkinson’s Disease
Assessment of heterogeneity among participants in the Parkinson's Progression Markers Initiative cohort using α-synuclein seed amplification: a cross-sectional study
Proposal for a Biologic Staging System of Parkinson’s Disease
Risk of Parkinson Disease Among Service Members at Marine Corps Base Camp Lejeune
Trichloroethylene: An Invisible Cause of Parkinson’s Disease?
Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression
LRRK2 and GBA1 variant carriers have higher urinary bis(monacylglycerol) phosphate concentrations in PPMI cohorts
American Football Play and Parkinson Disease Among Men
Prevalence and Incidence of Parkinson's Disease in Latin America: A Meta‐Analysis
Study in Parkinson’s disease of exercise phase 3 (SPARX3): study protocol for a randomized controlled trial
Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort
Remote smartphone monitoring of Parkinson’s disease and individual response to therapy
Genomewide Association Studies of <scp> <i>LRRK2</i> </scp> Modifiers of Parkinson's Disease
Prevalence of parkinsonism and Parkinson disease in urban and rural populations from Latin America: A community based study
Longitudinal Analysis of Multiple Neurotransmitter Metabolites in Cerebrospinal Fluid in Early Parkinson's Disease
Sex-Related Longitudinal Change of Motor, Non-Motor, and Biological Features in Early Parkinson’s Disease
The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism
Current and projected future economic burden of Parkinson’s disease in the U.S.
Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson's Disease Progression
The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease
Fox Insight collects online, longitudinal patient-reported outcomes and genetic data on Parkinson’s disease